[Betadrenol in the hyperkinetic heart syndrome and functional heart disorders].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008297:Male; D009497:Neurotic Disorders / Q000188:drug therapy*; D011412:Propanolamines / Q000627:therapeutic use*; D012893:Sleep Wake Disorders / Q000188:drug therapy; D013315:Stress, Psychological; D013577:Syndrome; D013610:Tachycardia / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines
Be;adrenol bei hyperkinetischem Herzsyndrom und funktionellen Herzbeschwerden.